BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23381842)

  • 1. A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia.
    Svetel MV; Djuric G; Novakovic I; Dobricic V; Stefanova E; Kresojevic N; Tomic A; Jankovic M; Petrovic I; Pekmezovic T; Kostic VS
    Acta Neurol Belg; 2013 Sep; 113(3):243-5. PubMed ID: 23381842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.
    Gómez-Garre P; Huertas-Fernández I; Cáceres-Redondo MT; Alonso-Canovas A; Bernal-Bernal I; Blanco-Ollero A; Bonilla-Toribio M; Burguera JA; Carballo M; Carrillo F; Catalán-Alonso MJ; Escamilla-Sevilla F; Espinosa-Rosso R; Fernández-Moreno MC; García-Caldentey J; García-Moreno JM; García-Ruiz PJ; Giacometti-Silveira S; Gutiérrez-García J; Jesús S; López-Valdés E; Martínez-Castrillo JC; Martínez-Torres I; Medialdea-Natera MP; Méndez-Lucena C; Mínguez-Castellanos A; Moya M; Ochoa-Sepulveda JJ; Ojea T; Rodríguez N; Sillero-Sánchez M; Vargas-González L; Mir P
    Mov Disord; 2014 Jul; 29(8):1083-6. PubMed ID: 24925604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia.
    Martino D; Muglia M; Abbruzzese G; Berardelli A; Girlanda P; Liguori M; Livrea P; Quattrone A; Roselli F; Sprovieri T; Valente EM; Defazio G
    Eur J Neurol; 2009 Aug; 16(8):949-52. PubMed ID: 19473353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males.
    Hou H; Qing Z; Jia S; Zhang X; Hu S; Hu J
    Brain Res; 2010 Sep; 1353():245-8. PubMed ID: 20655300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy.
    Agosti C; Borroni B; Archetti S; Akkawi NM; Padovani A
    Neurosci Lett; 2008 Oct; 443(3):228-31. PubMed ID: 18692116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
    Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.
    Kishikawa S; Li JL; Gillis T; Hakky MM; Warby S; Hayden M; MacDonald ME; Myers RH; Gusella JF
    Neurobiol Dis; 2006 Nov; 24(2):280-5. PubMed ID: 16962786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Hsu LE; Lin CH
    Neuropsychobiology; 2004; 49(1):10-2. PubMed ID: 14730194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China.
    Tang J; Xiao L; Shu C; Wang G; Liu Z; Wang X; Wang H; Bai X
    Neurosci Lett; 2008 Mar; 433(2):98-102. PubMed ID: 18242852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
    Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
    Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food restriction leads to binge eating dependent upon the effect of the brain-derived neurotrophic factor Val66Met polymorphism.
    Akkermann K; Hiio K; Villa I; Harro J
    Psychiatry Res; 2011 Jan; 185(1-2):39-43. PubMed ID: 20537407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.